Get started
Author

Emmanouil V. Dermitzakis

Observed names: Dermitzakis, Emmanouil, Dermitzakis, Emmanouil V., E. V. Dermitzakis, Emmanouil Dermitzakis, Emmanouil V Dermitzakis, Δερμιτζάκης, Εμμανουήλ Β
Institution: Euromedica
ORCID: 0000-0001-9275-0076
Observed ORCID: 0000-0001-9275-0076
OpenAlex ID: A5078782512
Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance
2016 · Luca A Lotta, Pawan Gulati, et al. · Nature Genetics · 599
Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective exploratory clinical study
2017 · Michail Vikelis, Emmanouil V. Dermitzakis, et al. · BMC Neurology · 52
PDF
OnabotulinumtoxinA Add-On to Monoclonal Anti-CGRP Antibodies in Treatment-Refractory Chronic Migraine
2022 · Andreas A. Argyriou, Emmanouil V. Dermitzakis, et al. · Toxins · 37
PDF
Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment
2018 · Michail Vikelis, Andreas A. Argyriou, et al. · The Journal of Headache and Pain · 36
PDF
The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer
2016 · Emmanouil V. Dermitzakis, Vasilios K. Kimiskidis, et al. · BMC Neurology · 34
PDF
Onabotulinumtoxin-A treatment in Greek patients with chronic migraine
2016 · Michail Vikelis, Andreas A. Argyriou, et al. · The Journal of Headache and Pain · 32
PDF
Headache patients in the emergency department of a Greek tertiary care hospital
2009 · Emmanouil V. Dermitzakis, Georgios Georgiadis, et al. · The Journal of Headache and Pain · 26
PDF
Efficacy and safety of fremanezumab for migraine prophylaxis in patients with at least three previous preventive failures: Prospective, multicenter, real‐world data from a Greek registry
2023 · Andreas A. Argyriou, Emmanouil V. Dermitzakis, et al. · European Journal of Neurology · 25
PDF
Long‐term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxis
2022 · Andreas A. Argyriou, Emmanouil V. Dermitzakis, et al. · Acta Neurologica Scandinavica · 25
Variability in oxidative stress-related genes (SOD2, CAT, GPX1, GSTP1, NOS3, NFE2L2, and UCP2) and susceptibility to migraine clinical phenotypes and features
2023 · Maria Papasavva, Michail Vikelis, et al. · Frontiers in Neurology · 23
PDF
Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry
2023 · Michail Vikelis, Emmanouil V. Dermitzakis, et al. · Journal of Clinical Medicine · 17
PDF
Switching between anti-CGRP monoclonal antibodies in migraine prophylaxis
2025 · Michail Vikelis, Dimitrios Rikos, et al. · Expert Review of Neurotherapeutics · 15
Analysis of HCRTR2, GNB3, and ADH4 Gene Polymorphisms in a Southeastern European Caucasian Cluster Headache Population
2019 · Maria Papasavva, Martha-Spyridoula Katsarou, et al. · Journal of Molecular Neuroscience · 15
The impact of oxaliplatin‐based chemotherapy for colorectal cancer on the autonomous nervous system
2014 · E. V. Dermitzakis, V. K. Kimiskidis, et al. · European Journal of Neurology · 15
Preferences and perceptions of 617 migraine patients on acute and preventive migraine treatment attributes and clinical trial endpoints
2024 · Michail Vikelis, Dimitrios Rikos, et al. · Expert Review of Neurotherapeutics · 14
Therapeutic Benefits of Short-Arm Human Centrifugation in Multiple Sclerosis–A New Approach
2022 · Chrysoula Kourtidou-Papadeli, Christos A. Frantzidis, et al. · Frontiers in Neurology · 13
PDF
Open Label Prospective Experience of Supplementation with a Fixed Combination of Magnesium, Vitamin B2, Feverfew, Andrographis Paniculata and Coenzyme Q10 for Episodic Migraine Prophylaxis
2020 · Michail Vikelis, Emmanouil V. Dermitzakis, et al. · Journal of Clinical Medicine · 13
PDF
Predictors of Response to Fremanezumab in Migraine Patients with at Least Three Previous Preventive Failures: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry
2023 · Andreas A. Argyriou, Emmanouil V. Dermitzakis, et al. · Journal of Clinical Medicine · 11
PDF
Effects of OnabotulinumtoxinA on Allodynia and Interictal Burden of Patients with Chronic Migraine
2024 · Andreas A. Argyriou, Emmanouil V. Dermitzakis, et al. · Toxins · 10
PDF
Single OnabotulinumtoxinA Session Add-On to Carbamazepine or Oxcarbazepine in Treatment-Refractory Trigeminal Neuralgia: A Case Series with 24-Week Follow Up
2023 · Georgia Xiromerisiou, Ioannis C. Lampropoulos, et al. · Toxins · 9
PDF
Results of a Web-Based Survey on 2105 Greek Migraine Patients—Second Part: Efficacy of Acute and Prophylactic Migraine Treatments and Corresponding Patients’ Reported Satisfaction
2022 · Emmanouil V. Dermitzakis, Aikaterini Kouroudi, et al. · Medicina · 8
PDF
Results of a Web-based survey of 2105 Greek migraine patients in 2020: demographics, clinical characteristics, burden and the effects of the COVID-19 pandemic on the course of migraine
2022 · Emmanouil V. Dermitzakis, Aikaterini Kouroudi, et al. · BMC Neurology · 8
PDF
Real-World Open-Label Experience with Rimegepant for the Acute Treatment of Migraine Attacks: A Multicenter Pilot Study
2024 · Emmanouil V. Dermitzakis, Dimitrios Rikos, et al. · Brain Sciences · 7
PDF
Nine-Month Continuous Fremanezumab Prophylaxis on the Response to Triptans and Also on the Incidence of Triggers, Hypersensitivity and Prodromal Symptoms of Patients with High-Frequency Episodic Migraine
2024 · Emmanouil V. Dermitzakis, Michail Vikelis, et al. · Journal of Clinical Medicine · 7
PDF
Workload of the emergency room neurologists and the neurological inpatient department in a Greek tertiary care hospital
2009 · Jobst Rudolf, Emmanouil V. Dermitzakis, et al. · Clinical Neurology and Neurosurgery · 7
Works count: 58
Citation count: 1,120
H-index: 14
I10-index: 19
Year
Topic
Type